The emergence of SARS-CoV-2 Omicron subvariants prompted countries to call for accelerated booster vaccinations to limit disease and transmission. Here, we characterized correlates of protection over time after the second booster or after Omicron BA.1 infection comparing variants of concern (VOCs). Sera from subjects before and two and seven weeks after the second booster or after Omicron infection were examined for the level of Spike receptor-binding-domain (RBD)-specific antibodies. Furthermore, neutralizing antibodies (nABs) were characterized in in vitro neutralization assays comparing the variants of concern Alpha, Beta, Delta, and Omicron BA.1 and BA.2 against the ancestral strain B.1. Here, the second booster resulted in an increase ...
BackgroundResults showing that sera from double vaccinated individuals have minimal neutralizing act...
Amid the ongoing global COVID-19 pandemic, limited literature exists on immune persistence after pri...
This study pictures the humoral response of 100 vaccinees to Pfizer/BioNTech COVID-19 vaccine over a...
International audienceThe third, "booster", vaccination increases the overall immune response agains...
Background: Results showing that sera from double vaccinated individuals have minimal neutralizing a...
Waning immunity against SARS-CoV-2 and the emergence of variants, especially of the most distant var...
IntroductionImmunocompromised patients have been shown to have an impaired immune response to COVID-...
BACKGROUND. Breakthrough SARS-CoV-2 infections in vaccinated individuals have been previously associ...
Background: The omicron variant has spread globally at unprecedented speed due to a combination of e...
Due to the rapid global spread of the Omicron (B.1.1.529) variant, efforts to scale up COVID-19 boos...
Evidence about the long-term persistence of the booster-mediated immunity against Omicron is mandato...
Background: The continuous emergence of SARS-CoV-2 variants of concern (VOC) with immune escape prop...
The SARS-CoV-2 variant Omicron has spread world-wide and is responsible for rapid increases in infec...
Infection-neutralizing antibody responses after SARS-CoV-2 infection or COVID-19 vaccination are an ...
© 2022 The Author(s)Omicron has become the globally dominant severe acute respiratory syndrome coron...
BackgroundResults showing that sera from double vaccinated individuals have minimal neutralizing act...
Amid the ongoing global COVID-19 pandemic, limited literature exists on immune persistence after pri...
This study pictures the humoral response of 100 vaccinees to Pfizer/BioNTech COVID-19 vaccine over a...
International audienceThe third, "booster", vaccination increases the overall immune response agains...
Background: Results showing that sera from double vaccinated individuals have minimal neutralizing a...
Waning immunity against SARS-CoV-2 and the emergence of variants, especially of the most distant var...
IntroductionImmunocompromised patients have been shown to have an impaired immune response to COVID-...
BACKGROUND. Breakthrough SARS-CoV-2 infections in vaccinated individuals have been previously associ...
Background: The omicron variant has spread globally at unprecedented speed due to a combination of e...
Due to the rapid global spread of the Omicron (B.1.1.529) variant, efforts to scale up COVID-19 boos...
Evidence about the long-term persistence of the booster-mediated immunity against Omicron is mandato...
Background: The continuous emergence of SARS-CoV-2 variants of concern (VOC) with immune escape prop...
The SARS-CoV-2 variant Omicron has spread world-wide and is responsible for rapid increases in infec...
Infection-neutralizing antibody responses after SARS-CoV-2 infection or COVID-19 vaccination are an ...
© 2022 The Author(s)Omicron has become the globally dominant severe acute respiratory syndrome coron...
BackgroundResults showing that sera from double vaccinated individuals have minimal neutralizing act...
Amid the ongoing global COVID-19 pandemic, limited literature exists on immune persistence after pri...
This study pictures the humoral response of 100 vaccinees to Pfizer/BioNTech COVID-19 vaccine over a...